BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4099595)

  • 1. [Influence of cyclic Ovosiston therapy on plasma lipid fractions of free cholesterol, total cholesterol and phospholipid].
    Carol W; Hempel E; Klinger G; Bünnig S
    Endokrinologie; 1970; 57(1):108-14. PubMed ID: 4099595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of a contraceptive treatment with Ovosiston on the serum-cholinesterase activity].
    Willgerodt H; Rothe K; Theile H; Fischer I
    Zentralbl Gynakol; 1971 Sep; 93(36):1261-7. PubMed ID: 4106443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term effects of the estrogen-gestagen combination preparation Ovosiston on glucose level in the insulin tolerance test].
    Goretzlehner G; Rudolf K; Töwe J
    Zentralbl Gynakol; 1974 Oct; 96(40):1249-53. PubMed ID: 4141548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effect of hormonal contraceptives on the behavior of serum lipids].
    Klinger G; Carol W; Hoppe H; Müller B; Bonow A
    Zentralbl Gynakol; 1977; 99(5):271-6. PubMed ID: 194435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A gradual method for a more physiological hormonal contraception].
    Hamann B; Büchner C
    Zentralbl Gynakol; 1976; 98(23):1445-9. PubMed ID: 65068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility control with 15-8-5.
    Andelman MB
    Fertil Steril; 1970 Apr; 21(4):314-21. PubMed ID: 4101384
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of the oral contraceptive Ovosiston on the composition of human milk.
    Ramadan MA; Salah MM; Eid SZ; Sammour MB
    J Reprod Med; 1972 Aug; 9(2):81-3. PubMed ID: 4115112
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver function studies under the influence of hormonal contraceptives (sequential preparations)].
    Brügmann E; Göretzlehner G; Dabels J; Töwe J
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):69-74. PubMed ID: 88322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in plasma lipids caused by oral contraceptives].
    Kaffarnik H
    Z Ernahrungswiss Suppl; 1972; 12():Suppl 12:67-72. PubMed ID: 4114609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endometrium during administration of sequence-ovosiston (report on 3 variants of sequential therapy)].
    Böhm W; Hempel E; Klinger G; Carol W
    Zentralbl Gynakol; 1972 Dec; 94(52):1816-20. PubMed ID: 4119792
    [No Abstract]   [Full Text] [Related]  

  • 12. [The serum levels of nonesterified fatty acids and free amino acids under the effect of the oral contraceptive, Ovosiston].
    Methfessel HD; Mlytz H; Liedtke MP; Löffler F; Methfessel G
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):880-2. PubMed ID: 4098228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of estrogen-gestagen drug combinations on carbohydrate and lipid metabolism. I. Effect of Ovosiston].
    Göretzlehner G; Herre HD; Töwe J
    Zentralbl Gynakol; 1973 Apr; 95(16):529-36. PubMed ID: 4123733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of serum copper and iron under the influence of the ovulation inhibitor Ovosiston].
    Methfessel HD; Mlytz H; Methfessel G; Löffler F
    Z Gesamte Inn Med; 1969 Oct; 24(19):659-61. PubMed ID: 4188438
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of injectable contraceptive on lipid metabolism in women.
    Kandeel KM; Nayel SA; Abaza MS
    Biomed Biochim Acta; 1984; 43(1):111-5. PubMed ID: 6721873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endometrium in "contraception cycle" under Ovosiston].
    Böhm W; Möbius W; Müller W
    Zentralbl Gynakol; 1969 Oct; 91(43):1412-8. PubMed ID: 4100318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1st clinical experiences on the use of oral contraceptive Ovosiston in diabetics].
    Gödel E; Gödel B
    Dtsch Gesundheitsw; 1970 Apr; 25(14):627-31. PubMed ID: 4098543
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with Ovosiston for inhibition of ovulation].
    Kühne D
    Dtsch Gesundheitsw; 1966 Feb; 21(8):377-9. PubMed ID: 4165201
    [No Abstract]   [Full Text] [Related]  

  • 20. [Towards a more physiological hormonal contraception].
    Stĕrba R
    Zentralbl Gynakol; 1970 Mar; 92(10):303-12. PubMed ID: 4096927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.